FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 3 R

MDR report key: 15361268 · Received September 6, 2022

Report

Report Number
3005180920-2022-00677
Event Type
Injury
Date Received
September 6, 2022
Date of Event
August 11, 2022
Report Date
September 6, 2022
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030825828
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 23-AUG-2022: LOT 2100329: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 24-MAR-2021. EXPIRATION DATE: 2026-03-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. ADDITIONAL DEVICES INVOLVED BATCH REVIEW PERFORMED ON 23-AUG-2022: GMK-SPHERE 02.12.0311FR TIBIAL INSERT FIXED SPHERE FLEX SIYE 3/11 MM R (K140826) LOT 2009017: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 10-NOV-2020. EXPIRATION DATE: 2025-10-25. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. GMK-SPHERE 02.07.1203R TIBIAL TRAY FIXED CEMENTED SIZE 3 R (K090988) LOT 2010237: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 25-FEB-2021. EXPIRATION DATE: 2026-02-15. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 1 YEAR AND 1 MONTH AFTER THE PRIMARY SURGERY, THE PATIENT CAME IN DUE TO SIGNS OF INFECTION AND THE PATHOGEN IS UNKNOWN. THE SURGEON REVISED ALL IMPLANTS EXCEPT THE PATELLA, AND RE-IMPLANTED PERMANENT HARDWARE. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2561647 GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 3 R KNEE FEMORAL COMPONENT JWH MEDACTA INTERNATIONAL SA 02.12.0003R 2100329 07630030825828

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention